Fumin Jia1, Hongwei Hao1, Fangang Meng2, Yi Guo3, Shizhong Zhang4, Jianguo Zhang2, Luming Li1. 1. a National Engineering Laboratory for Neuromodulation , Tsinghua University , Beijing , China. 2. b Department of Functional Neurosurgery , Beijing Neurosurgical Institute , Beijing , China. 3. c Department of Neurosurgery , Peking Union Medical College Hospital , Beijing , China. 4. d Department of Neurosurgery, Zhujiang Hospital , Southern Medical University , Guangzhou , China.
Abstract
PURPOSE/AIM OF THE STUDY: Rechargeable deep brain stimulation (DBS) system with longer battery life has become available for treating movement disorders. However, little information exists about the safety and management after implantation. Therefore, there is an urgent need to evaluate the recharging performance through long-term observations. MATERIALS AND METHODS: Fifty-three Parkinson's disease (PD) patients were implanted with a new rechargeable device (G102R, PINS Medical). They were observed at the baseline and 3 months, 6 months and 12 months after surgery, with measurement of the acceptance, frequency, recharging time and feeling during recharging. RESULTS: The patients with the ages between 34 and 70 (57.64 ± 7.34) years thought the system was very easy to recharge. The favorite time interval for recharging was 1 week, and 10 days and half a month also chosen. Most of the patients spent around 1 hour recharging, with no unacceptable hot feelings reported. CONCLUSIONS: The PD patients could easily and safely recharge this new rechargeable implantable neurostimulators. Thus, these neurostimulators might be an excellent choice for PD patients.
PURPOSE/AIM OF THE STUDY: Rechargeable deep brain stimulation (DBS) system with longer battery life has become available for treating movement disorders. However, little information exists about the safety and management after implantation. Therefore, there is an urgent need to evaluate the recharging performance through long-term observations. MATERIALS AND METHODS: Fifty-three Parkinson's disease (PD) patients were implanted with a new rechargeable device (G102R, PINS Medical). They were observed at the baseline and 3 months, 6 months and 12 months after surgery, with measurement of the acceptance, frequency, recharging time and feeling during recharging. RESULTS: The patients with the ages between 34 and 70 (57.64 ± 7.34) years thought the system was very easy to recharge. The favorite time interval for recharging was 1 week, and 10 days and half a month also chosen. Most of the patients spent around 1 hour recharging, with no unacceptable hot feelings reported. CONCLUSIONS: The PDpatients could easily and safely recharge this new rechargeable implantable neurostimulators. Thus, these neurostimulators might be an excellent choice for PDpatients.
Entities:
Keywords:
Parkinson's disease; battery life; deep brain stimulation; rechargeable; safety
Authors: Kyle T Mitchell; Monica Volz; Aaron Lee; Marta San Luciano; Sarah Wang; Philip A Starr; Paul Larson; Nicholas B Galifianakis; Jill L Ostrem Journal: Stereotact Funct Neurosurg Date: 2019-07-09 Impact factor: 1.875